Skip to main content

Injection Procedure Codes J2020 and J2250 Now a Benefit of the CSHCN Services Program

Last updated on

Beginning December 1, 2022, for dates of service on or after November 1, 2022, injection procedure codes J2020 for Zyvox (linezolid) and J2250 for midazolam hydrochloride are a benefit of the Children with Special Health Care Needs (CSHCN) Services Program for clients of all ages.

Procedure codes J2020 and J2250 are a benefit of the CSHCN Services Program for the following providers and places of service:

Place of Service

Provider Type

Office

Physician assistant, nurse practitioner, clinical nurse specialist, physician, clinic/group practice

Outpatient hospital

Hospital

Any affected claims will be reprocessed. Providers are not required to appeal the claims unless the claims are denied for additional reasons after reprocessing is completed.

For more information, call the TMHP-CSHCN Services Program Contact Center at 800-568-2413.